Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Return on Sales (2016 - 2026)

Pharma-Bio Serv (PBSV) has disclosed Return on Sales for 16 consecutive years, with 0.0% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Sales fell 1.0% year-over-year to 0.0%, compared with a TTM value of 0.04% through Oct 2025, up 4.0%, and an annual FY2025 reading of 0.01%, up 7.0% over the prior year.
  • Return on Sales was 0.0% for Q4 2025 at Pharma-Bio Serv, up from 0.16% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.46% in Q3 2021 and bottomed at 0.87% in Q4 2021.
  • Average Return on Sales over 5 years is 0.02%, with a median of 0.03% recorded in 2021.
  • The sharpest move saw Return on Sales crashed -90bps in 2021, then soared 92bps in 2022.
  • Year by year, Return on Sales stood at 0.87% in 2021, then skyrocketed by 106bps to 0.05% in 2022, then crashed by -128bps to 0.01% in 2023, then surged by 149bps to 0.01% in 2024, then plummeted by -101bps to 0.0% in 2025.
  • Business Quant data shows Return on Sales for PBSV at 0.0% in Q4 2025, 0.16% in Q3 2025, and 0.04% in Q2 2025.